Real World Evidence Solutions Market Size, Share, By Component (Claims Data, Clinical Settings Data, Patient-Powered Data, Pharmacy Data, and Others), By Application (Drug Development, and Drug Approvals), By End- Use (Healthcare Payers, Healthcare Providers, Pharmaceutical and Medical Device Companies, and Others), and By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis and Forecast till 2034

Report Code: PMI531024 | Publish Date: June 2024 | No. of Pages: 183

Real World Evidence Solutions Market Companies

Recent News:

In April 2024, Palantir Technologies Inc. and Parexel joined to use AI to speed up and improve the delivery of efficient and secure clinical trials for clients in the global biopharmaceutical industry. Through the partnership, Paraxel's strengths in advanced analytics, RWE, and health outcomes are expanded, and improved clinical trial processes are made possible.
In April 2024, IQVIA and Salesforce announced they would expand their strategic cooperation to accelerate the development of Salesforce's Life Sciences Cloud. This project is a next-generation platform for consumer engagement in the life sciences industry. Using these tactical alliances, IQVIA hopes to create further technology-based solutions that will quicken decision-making procedures in several areas, including RWE, discovery, clinical development, medical affairs, and patient safety.
In October 2021, The Real-World Evidence Registry was introduced by the Real-World Evidence Transparency Initiative to create a transparent culture for reporting and analyzing real-world evidence in medical research and healthcare. The International Society for Pharmacoepidemiology, the National Pharmaceutical Council, the Duke-Margolis Centre for Health Policy, and ISPOR collaborate to create the Real-World Evidence Transparency Initiative.